Table 3:
CT Characteristic Presenta | IASLC/ITMIG TNM Stage OR (95% CI) | T Stage OR (95% CI) | Masaoka-Koga Stage OR (95% CI) | Resection Status OR (95% CI) | WHO Histology OR (95% CI) |
---|---|---|---|---|---|
Size | 1.23 (0.98–1.54) p=0.08 |
NS | 1.21 (0.98–1.50) p=0.08 |
NS | NS |
Lobulated contour | INFb (1.75-INF) p=0.005 |
INFb (1.43-INF) p=0.01 |
6.71 (1.33–33.78) p=0.02 |
INFb (INF-1.03) p=0.05 |
NS |
Heterogeneous internal density | NS | NS | NS | NS | NS |
Calcification | NS | 2.93 (0.86–10.05) p=0.09 |
NS | NS | NS |
Infiltration of mediastinal fat | 5.04 (1.39–18.24) p=0.014 |
9.97b (2.30–43.18) p=0.002 |
3.74 (1.05–13.31) p=0.04 |
8.76 (2.17–35.30) P=0.002 |
2.91 (0.85–9.96) p=0.09 |
Abutment of ≥50% of mediastinal vessels | NS | 6.16 (1.49–25.53) p=0.01 |
NS | NS | 3.15 (0.95–10.53) p=0.06 |
Vascular endoluminal invasion | INFb (2.92-INF) p=0.0007 |
INFb (3.60-INF) p=0.0003 |
INFb (2.92-INF) p=0.0007 |
INFb (5.21-INF) p<0.0001 |
INFb (1.22-INF) p=0.02 |
Abutment of adjacent mediastinal structures | NS | NS | NS | NS | NS |
Invasion of adjacent mediastinal structures | 6.53 (1.89–22.58) p=0.003 |
6.04 (1.66–22.00) P=0.006 |
5.97 (1.72–20.76) p=0.005 |
4.84 (1.26–18.65) p=0.02 |
NS |
Elevated hemidiaphragm | INFb (2.29-INF) p=0.002 |
11.67b (1.03–620.72) p=0.02 |
INFb (2.29-INF) p=0.002 |
NS | NS |
Pleural effusion | NS | NS | NS | NS | NS |
Pleural nodule | 3.78 (0.82–17.30) p=0.09 |
NS | NS | 4.28 (0.78–23.43) p=0.09 |
NS |
Mediastinal lymph node enlargement | NS | NS | NS | NS | NS |
Abbreviations: OR=odds ratio, CI=confidence interval, cm=centimeter, NS=not significant, INF=infinity
Proportional odds regression model used to determine likelihood of more advanced stage, incomplete resection status, and more aggressive WHO histology. Odds ratios that are significant (p<0.05) or trended for significance are reported (≤0.05p<0.10).
Fisher’s exact test used if subgroup <6 to provide more accurate point estimate.